
Sign up to save your podcasts
Or


Lynn Nichols Federal Tax Update Podcast
April 2, 2018, edition
Listen as Lynn Nichols provides commentary on 6 Items pertaining to current developments in U.S. tax law. This week's topics include:
OUR PROGRAM THIS WEEK INCLUDES . . . . . .
Karen Sowell of the New York State Bar Association Tax Section has submitted comments to address various technical and interpretative issues that have arisen as a result of the addition of section 199A by the Tax Cuts and Jobs Act (P.L. 115-97).
[Tax Notes Today; 3/26/2018]
A divided panel of the Third Circuit affirmed a Tax Court decision that held that a pharmaceutical scientist didn't transfer all substantial rights to the liquisolid drug technology he developed and, thus, subjected royalties he received under a licensing agreement with a drug company to treatment as ordinary income and not capital gains under section 1235.
[Spireas , Spiridon v. Commissioner; CA 3; No. 17-1084; 3/26/2018]
A U.S. district court, denying a partnership's request to amend its complaint, held that $11 million in grants the partnership received from the New York State Empire State Development Corp. for restoration of a former federal building constituted income for federal income tax purposes and were not excludable from income.
[Uniquest Delaware LLC et al. v. United States; WD NY; No. 1:15-cv-00638 ; 3/27/2018]
[INFO 2018-0001; 1/11/2018; rel. 3/30/2018
[INFO 2018-0003; 1/5/2018; rel. 3/30/2018
[INFO 2018-0004; 2/8/2018; rel. 3/30/2018]
By SCACPA Lynn NicholsLynn Nichols Federal Tax Update Podcast
April 2, 2018, edition
Listen as Lynn Nichols provides commentary on 6 Items pertaining to current developments in U.S. tax law. This week's topics include:
OUR PROGRAM THIS WEEK INCLUDES . . . . . .
Karen Sowell of the New York State Bar Association Tax Section has submitted comments to address various technical and interpretative issues that have arisen as a result of the addition of section 199A by the Tax Cuts and Jobs Act (P.L. 115-97).
[Tax Notes Today; 3/26/2018]
A divided panel of the Third Circuit affirmed a Tax Court decision that held that a pharmaceutical scientist didn't transfer all substantial rights to the liquisolid drug technology he developed and, thus, subjected royalties he received under a licensing agreement with a drug company to treatment as ordinary income and not capital gains under section 1235.
[Spireas , Spiridon v. Commissioner; CA 3; No. 17-1084; 3/26/2018]
A U.S. district court, denying a partnership's request to amend its complaint, held that $11 million in grants the partnership received from the New York State Empire State Development Corp. for restoration of a former federal building constituted income for federal income tax purposes and were not excludable from income.
[Uniquest Delaware LLC et al. v. United States; WD NY; No. 1:15-cv-00638 ; 3/27/2018]
[INFO 2018-0001; 1/11/2018; rel. 3/30/2018
[INFO 2018-0003; 1/5/2018; rel. 3/30/2018
[INFO 2018-0004; 2/8/2018; rel. 3/30/2018]